© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
August 15, 2011
With the FDA extending the public comment period on the development of a Risk Evaluation and Mitigation Strategy (REMS) for opioid drug products until October 2010, there's still time for physicians, pharmacists, and patients to make their voices heard.
Just how well do you know your patients? Every day physicians across the country treat patients from all different walks of life-some they've known for years, others they see once or twice a year, and some are new patients whom they know little about other than what they've read off initial forms.
More than 200 years have passed since the discovery of morphine in 1804 (http://hcp.lv/dCk9eP). Although the management of pain has come a long way-incorporting new technologies and featuring more diverse pharmacologic solutions-the price of seeking relief still comes with many of the same consequences, mainly in the form of addiction.
October 21, 2010
Peter Libby, MD, discusses the science behind inflammation and cardiovascular health.
Predominantly Persistent IRF in nAMD Eyes Linked to Worse Long-Term Visual Acuity
Mean Changes in Visual Acuity Linked to Anti-VEGF Treatment Intensity
Higher Mortality Rate for NAFLD Patients With Fatigue